32
Participants
Start Date
March 12, 2021
Primary Completion Date
July 12, 2021
Study Completion Date
July 12, 2021
50 mg/mL Virazole Inhalant Product
50 mg/mL Virazole (10 or 20 ml total volume) aerosolized and administered until solution depleted
100 mg/mL Virazole Inhalant Product
100 mg/mL Virazole (10 or 20 ml total volume) aerosolized and administered until solution depleted
Placebo
Placebo (10 or 20 ml total volume) aerosolized and administered until solution depleted
Bausch Site 1, Mississauga
Bausch Health Americas, Inc.
INDUSTRY